Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/12/010995
CTRI/2017/12/010995
Completed
Phase 2

A Clinical Study to Evaluate the Efficacy and Safety of Marham Kharish Jadeed in the Management of Quba (Tinea Corporis) - TMKJ

Central Research Institute of Unani Medicine0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Research Institute of Unani Medicine
Enrollment
60
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients having Quba (Tinea corporis) with the following signs and symptom:
  • •c.Scaling of lesion
  • •d.Central clearing with peripheral raised margins
  • •2\.Patients with a mycological diagnosis of Tinea Corporis confirmed by microscopic KOH wet mount

Exclusion Criteria

  • •1\.All other clinical types of tinea infections
  • •2\.Patients with secondary bacterial infections/ Diabetes Mellitus
  • •3\.Pregnant and lactating women
  • •4\.Significant Pulmonary/Cardiovascular/Hepato\-renal Dysfunction
  • •5\.Known cases of Immunocompromised states (HIV/ AIDS, etc.)
  • •6\.History of hypersensitivity to Terbinafine and Marham Kharish Jadeed
  • •7\.Patients using the following medications:
  • •8\.Topical antifungal agent/ topical corticosteroids in treatment area within 30 days of baseline visit
  • •9\.Systemic anti\-fungals within 8 weeks of baseline visit (8 months for oral Terbinafine)
  • •10\.Systemic corticosteroids within 30 days of baseline visit

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Treatment of ithy, red, dry and cracked skin condition (Eczema) by of Unani drug
CTRI/2017/12/010957Central Research Institute of Unani Medicine
Completed
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis BullosaEpidermolysis Bullosa
JPRN-UMIN000026645Osaka University6
Recruiting
Not Applicable
Evaluation of the usefulness and safety of the combined use of an ear prosthesis and a cartilage conduction hearing aid
JPRN-UMIN000044711Keio University30
Completed
Phase 2
Clinical comparative efficacy and safety of Polyherbal Unani formulations.Health Condition 1: K120- Recurrent oral aphthae
CTRI/2023/02/049696State Unani Medical College, himmatganj Prayagraj40
Not yet recruiting
Phase 2
Effectiveness of Unani Drugs in High Blood Pressure
CTRI/2017/12/011006Central Research Institute of Unani Medicine